Christie, Parker & Hale, LLP
Process for increasing the yield of a protein which has been subjected to viral inactivation
 The present invention is directed to a process for purifying alpha-1-PI. The process comprises providing an impure protein fraction which comprises alpha-1-PI. The impure protein fraction is suspended in an aqueous solution at pH 6. Insoluble proteins are recovered and resuspended in aqueous solution at pH 8.5. PEG is added to precipitate .alpha.-2 proteins. To the PEG supernatant precipitation, which comprises alpha-1-PI, is added ZnCl.sub.2 to precipitate crude alpha-1-PI. The crude alpha-1-PI is resolubilized and applied to an anion-exchange medium. A fraction comprising alpha-1-PI is recovered from the anion-exchange medium. Alpha-1-PI purified by the process has a specific activity about 1.0 units/OD.sub.280. 
Alpha Therapeutic Corporation
Y Y C C
Y10S Y10S C07K C07K
additional additional inventional inventional
Duk Sung Hirokazu Kazuo Mark Lyndon Evelyn
Hwang Ito Takechi Lepe Luz Nario